Venture Capital
Vitestro
Vistestro receives an investment of €60 million from Labcorp Venture Fund, Mayo Clinic and Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital and ROM Utrecht, Invest NL, EIC Fund, NYBC Ventures and Sonder Capital.
The Utrecht-based medtech company Vitestro, specialized in autonomous blood collection using medical robotics, has secured an investment. With this investment, Vitestro can further develop the next generation of its autonomous blood collection system and prepare it for an international market launch. The initial broader rollout starts in the Netherlands, followed by the rest of Europe and later the United States.
